Cargando…
Adjuvant breast cancer chemotherapy during late-trimester pregnancy: not quite a standard of care
BACKGROUND: Diagnosis of breast cancer during pregnancy was formerly considered an indication for abortion. The pendulum has since swung to the other extreme, with most reviews now rejecting termination while endorsing immediate anthracycline-based therapy for any pregnant patient beyond the first t...
Autor principal: | Epstein, Richard J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1894980/ https://www.ncbi.nlm.nih.gov/pubmed/17537241 http://dx.doi.org/10.1186/1471-2407-7-92 |
Ejemplares similares
-
Against – 3D ultrasound in first and second trimester pregnancy – hype or helpful?
por: Vaughan, Janet I
Publicado: (2015) -
The optimal sequence of radiotherapy and chemotherapy in adjuvant treatment of breast cancer
por: Abbas, Hamza, et al.
Publicado: (2011) -
For – 3D ultrasound in first and second trimester – hype or helpful?
por: Davis, Richard
Publicado: (2015) -
Exclusive and adjuvant radiotherapy in breast cancer patients with synchronous metastases
por: Le Scodan, Romuald, et al.
Publicado: (2010) -
Higher locoregional recurrence rate for triple-negative breast cancer following neoadjuvant chemotherapy, surgery and radiotherapy
por: Zhang, Chi, et al.
Publicado: (2015)